Mrs. Lindsey Aaron Smith, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 201 Erie St, Suite C, Grove City, PA 16127 Phone: 724-458-7005 Fax: 724-458-5297 |
Jennifer Marie Martello, CRNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 631 N Broad Street Ext Ste 101, Grove City, PA 16127 Phone: 724-450-7010 Fax: 724-450-7011 |
Rosemarie Seibert, CRNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 450 Hillcrest Ave, Grove City, PA 16127 Phone: 724-264-4864 Fax: 724-264-4865 |
Heather Karenbauer, Nurse Practitioner - Women's Health Medicare: Accepting Medicare Assignments Practice Location: 647 N Broad Street Ext, Suite 106, Grove City, PA 16127 Phone: 724-458-7737 |
Stephanie Schagrin, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 647 N Broad Street Ext Ste 101, Grove City, PA 16127 Phone: 724-450-7010 |
Anne Leali, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 420 Hillcrest Ave, Grove City, PA 16127 Phone: 724-458-4950 |
News Archive
Massachusetts General Hospital investigators have made an important step towards greater availability of hand transplants, face transplants and other transplants involving multiple types of tissue.
CQ Healthbeat reports the Office of Management and Budget is reviewing several health law implementation rules including this one, which will determine the types of coverage available to consumers. Meanwhile, a study examines how the health law's caps on out-of-pocket costs will affect consumers next year.
SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry and EGEN, Inc., a privately held biopharmaceutical company focused on developing nucleic acid (DNA and RNAi) therapeutics for the treatment of human diseases, are pleased to announce they have executed a continuation of their feasibility collaboration focused on long-term controlled release of siRNA complexes.
It is announced today that CNS Network has purchased ALPHADAS®, Logos Technologies Inc's early phase, e-source data capture system and site automation tools to accelerate and streamline its clinical trials. ALPHADAS is to be implemented in their Orange County Research Center, California, USA.
Scientists from the Florida campus of The Scripps Research Institute have been awarded just over $1 million from the National Institutes of Health for a three-year study to develop new high-throughput screening tests to find compounds that disable a protein essential to hepatitis C virus (HCV) replication.
› Verified 5 days ago